Profusa, Inc. Common Stock
Symbol: PFSA (NASDAQ)
Company Description:
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
- Today's Open: $0.31
- Today's High: $0.33
- Today's Low: $0.267
- Today's Volume: 1.24M
- Yesterday Close: $0.3153
- Yesterday High: $0.3334
- Yesterday Low: $0.28
- Yesterday Volume: 1.14M
- Last Min Volume: 1.16K
- Last Min High: $0.28
- Last Min Low: $0.28
- Last Min VWAP: $0.28
- Name: Profusa, Inc. Common Stock
- Website: https://www.profusa.com
- Listed Date: 2025-07-14
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001859807
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $10.39M
- Round Lot: 100
- Outstanding Shares: 36.09M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-10 | PRE 14A | View |
2025-09-04 | 8-K | View |
2025-08-29 | S-1 | View |
2025-08-26 | 8-K | View |
2025-08-25 | EFFECT | View |
2025-08-25 | 424B3 | View |
2025-08-22 | S-1/A | View |
2025-08-21 | S-1/A | View |
2025-08-19 | 8-K | View |
2025-08-18 | DEF 14A | View |
2025-08-15 | 8-K/A | View |
2025-08-14 | 10-Q | View |
2025-08-11 | S-1 | View |
2025-08-11 | PRE 14A | View |
2025-08-07 | 8-K | View |
2025-07-28 | 8-K | View |
2025-07-24 | SCHEDULE 13G | View |
2025-07-22 | 3 | View |
2025-07-21 | 3 | View |
2025-07-18 | 8-K | View |